The incident device is anticipated to return.A follow-up report will be provided upon completion of investigation.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when the initial report was submitted, then the supplemental report will be submitted to the fda.
|
Investigation summary: one (1) 10mm trocar sleeve was returned for evaluation.Upon visual inspection, engineering confirmed that the shield was fully dislodged from the seal of the trocar.Upon further inspection, engineering disassembled the 10mm sleeve and found that the septum and duckbill were torn.Two tears were found near the bottom opening of the septum and one tear was found on the bottom edge of the duckbill.All gelpoint® minis undergo 100% visual inspection during the assembly and packaging process.The most likely root cause of the shield dislodging would be inserting an instrument non-axially into the sleeve.There is always a potential to tear or dislodge the internal seal components with multiple passes of instruments, especially with sharp or angular devices.The instructions for use (ifu) warns "extra care should be used when inserting angular and asymmetrical instruments.To minimize eversion of the sleeve's seal, instruments with high textured surfaces should be coated with a sterile lubricant." although the root cause of the event could not be confirmed, applied medical will continue to monitor its vigilance system for trends and take appropriate actions as necessary.Additional information requested and received.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when this report was submitted, then the supplemental report will be submitted to the fda.
|